Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
76,643.96
(
-0.06%
)
News Focus
News Focus
Post# of 20777
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

qotsa55

Send PM Follow Ignore
Followers 5
Posts 435
Boards Moderated 0
Alias Born 04/05/2012

qotsa55

Re: mkaiz post# 11392

Saturday, 12/21/2013 7:53:00 PM

Saturday, December 21, 2013 7:53:00 PM

Post# of 20777
mkaiz..that was an old article from before the phase 3 trials came out for both Bapi and Solanezumab. They both failed to reach their endpoints. However, I believe Bapi might still have a chance at being studied for treatment in the earliest stages of Alzheimer's. Solanezumab I believe received 100 million dollar grant and is back in phase 3 studies already. I believe the results for those phase 3 trials are due in 2018
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today